PRISCIANDARO, MICHELE

PRISCIANDARO, MICHELE  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 2022 Raimondi, AlessandraPrisciandaro, MicheleSartore-Bianchi, AndreaDi Bartolomeo, Mariade Braud, FilippoPietrantonio, Filippo + Article (author) -
TREMELIMUMAB AND DURVALUMAB COMBINATION FOR THE NON-OPERATIVE MANAGEMENT OF MICROSATELLITE INSTABILITY HIGH RESECTABLE GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER: RESULTS OF COHORT 1 OF THE MULTICENTRE, SINGLE-ARM, MULTI-COHORT, PHASE II INFINITY STUDY 2022 PRISCIANDARO, MICHELE Doctoral Thesis -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 2021 Sartore-Bianchi A.Prisciandaro M.Pietrantonio F. + Article (author) -
Personalized therapeutic strategies in HER2-driven gastric cancer 2021 Pietrantonio, FilippoDe Pascale, StefanoRausa, EmanueleSiena, SalvatoreSartore-Bianchi, AndreaRaimondi, AlessandraPrisciandaro, Michele + Article (author) -
Tremelimumab and durvalumab combination for the non-operative management (NOM) of microsatellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer : The multicentre, single-arm, multi-cohort, phase II INFINITY study 2021 Prisciandaro M.Sposito C.Mazzaferro V.Pietrantonio F. + Article (author) -
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 2021 Manca P.Corallo S.Randon G.Tomasello G.Prisciandaro M.Di Bartolomeo M.de Braud F.Pietrantonio F. + Article (author) -
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 2021 Toscano G.Tomasello G.Petrelli F.Prisciandaro M.Randon G.de Braud F.Di Bartolomeo M.Pietrantonio F. + Article (author) -
Recent Advances in the Management of Typical and Atypical Lung Carcinoids 2021 Rossi R. E.Torchio M.Prisciandaro M.Spreafico C.Beninato T.de Braud F. + Article (author) -
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 2021 Corti, FrancescaAmbrosini, MargheritaManca, PaoloRaimondi, AlessandraPrisciandaro, MicheleCurigliano, GiuseppeDe Braud, FilippoDi Bartolomeo, MariaPietrantonio, Filippo + Article (author) -
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 2021 Pietrantonio, Filippode Pascale, StefanoRausa, EmanueleSiena, SalvatoreSartore-Bianchi, AndreaPrisciandaro, Michele + Article (author) -
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 2021 Manca P.Sartore Bianchi A.Randon G.Prisciandaro M.Pietrantonio F. + Article (author) -
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients : A Multi-institutional Analysis 2020 Pagani FPrisciandaro MManglaviti SPietrantonio F + Article (author) -
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 2020 Pietrantonio FRandon GRaimondi APagani FPrisciandaro MCorti FMarra ACurigliano Gde Braud F. + Article (author) -
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 2020 Prisciandaro M.Sposito C.Mazzaferro V.de Braud F.Pietrantonio F. + Article (author) -
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials. 2020 Prisciandaro MDe Braud FPietrantonio F + Article (author) -
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 2020 Pietrantonio, FilippoPrisciandaro, MicheleRandon, GiovanniCorti, FrancescaAmbrosini, MargheritaSposito, CarloMazzaferro, Vincenzode Braud, Filippo + Article (author) -
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial 2020 Pietrantonio FManca PPagani FRaimondi APrisciandaro MRandon GCorti Fde Braud F + Article (author) -
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 2019 Vernieri, ClaudioPrisciandaro, MicheleMaggi, ClaudiaMennitto, AlessiaFabbroni, ChiaraFarè, Elenade Braud, Filippo + Article (author) -
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma 2019 Indini, AlicePrisciandaro, MicheleRandon, GiovanniDe Braud, Filippo + Article (author) -